KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Share-based Compensation (2016 - 2025)

Evolent Health (EVH) has 11 years of Share-based Compensation data on record, last reported at $2.4 million in Q4 2025.

  • For Q4 2025, Share-based Compensation rose 139.18% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $39.7 million, changed 0.02%, while the annual FY2025 figure was $39.7 million, 0.02% changed from the prior year.
  • Share-based Compensation reached $2.4 million in Q4 2025 per EVH's latest filing, down from $14.7 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $18.8 million in Q1 2024 and bottomed at -$6.1 million in Q4 2024.
  • Average Share-based Compensation over 5 years is $8.5 million, with a median of $9.6 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: soared 195.16% in 2022, then plummeted 157.67% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $5.0 million in 2021, then surged by 195.16% to $14.6 million in 2022, then dropped by 27.53% to $10.6 million in 2023, then tumbled by 157.67% to -$6.1 million in 2024, then surged by 139.18% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $2.4 million in Q4 2025, $14.7 million in Q3 2025, and $11.6 million in Q2 2025.